Dong-A Socio Holdings Co.,Ltd Logo

Dong-A Socio Holdings Co.,Ltd

Holding company with businesses in pharmaceuticals, medical devices, and food/beverages.

000640 | KO

Overview

Corporate Details

ISIN(s):
KR7000640003
LEI:
Country:
South Korea
Address:
서울특별시 동대문구 천호대로 64, 서울특별시

Description

Dong-A Socio Holdings is a holding company that manages a diverse group of businesses centered on healthcare. Its operations span pharmaceuticals, medical devices, food and beverages, and logistics. The group includes key subsidiaries such as Dong-A ST, which focuses on the research and development of ethical drugs, biologics, and innovative new treatments, including AI-based drug discovery. Dong-A Pharmaceutical develops and markets a wide range of over-the-counter healthcare products, consumer goods, and cosmetics. Other specialized affiliates include Dong-A Chammed, providing medical devices and diagnostic solutions, and Aptis, which develops advanced Antibody-Drug Conjugate (ADC) technology. The group also manages popular food and beverage brands.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-04-24 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.5 KB
2025-04-07 00:00
최대주주등소유주식변동신고서
Korean HTML 86.4 KB
2025-04-07 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 401.1 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.2 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.1 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.9 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.0 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.0 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.0 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.0 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.0 KB
2025-04-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.0 KB
2025-03-31 00:00
정기주주총회결과
Korean HTML 28.0 KB
2025-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean HTML 10.7 KB
2025-03-21 00:00
감사보고서제출(자회사의 주요경영사항)
Korean HTML 27.6 KB

Automate Your Workflow. Get a real-time feed of all Dong-A Socio Holdings Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dong-A Socio Holdings Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dong-A Socio Holdings Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.